EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

Optimizing expanded carrier screening for China: Multi-center study establishes 202-gene panel with optimal cost-effectiveness in preconception and prenatal care

Yulu Yang, Yuting Hang, WeiSheng Cheng, Yunxia Cao, Zhaolian Wei, Jing Yuan iD

PLOS One · 2026

DOI: 10.1371/journal.pone.0338642 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift PLOS One, 2026. Verfasst von Yulu Yang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, the First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China. Hauptthemen laut MEDLINE: Genetic Carrier Screening, Genetic Testing, Preconception Care, Prenatal Care. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China Stem Cell and Translational Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To evaluate the cost-effectiveness of different expanded carrier screening (ECS) panels for couples in China during preconception and early pregnancy (≤12 +6 weeks) based on a multi-center cohort study.

Methods

A multicenter, population-based study was conducted across 22 prenatal diagnosis centers in China from August 2022 to June 2023, enrolling 2,996 participants. Geographical distribution and at-risk gene frequencies were analyzed, categorizing the 222-gene panel into three groups: Panel A (222 genes), Panel B (188 genes, compliant with international guidelines), and Panel C (202 genes, optimized for the Chinese population). Decision-tree models assessed cost-effectiveness in two clinical scenarios: Preconception and During Pregnancy. Additionally, two distinct outcomes were employed: payoff 1 was defined as the number of necessary medically termination, while payoff 2 was the number of newborns free of recessive monogenic disorders.

Results

As anticipated, European screening recommendations demonstrated limited applicability to the Chinese population. Panel A incurred the highest total cost in both the Preconception (US $5,214) and During Pregnancy (US $990) models. In the Preconception model, the incremental cost-effectiveness ratio for Panel C was US $74,869 per necessary termination and US $23,999 per additional healthy newborn without genetic disorders, compared to Panel B. In the During Pregnancy model, Panel B was the most cost-effective, yielding savings of US $580 per necessary termination and US $2,052 per healthy newborn compared to Panel C.

Conclusion

For Chinese couples, the 202-gene panel (Panel C) is the most cost-effective option in both preconception and prenatal settings. However, for couples prioritizing comprehensive screening over cost, the 222-gene panel (Panel A) provides greater clinical value at a higher cost.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Genetic Carrier ScreeningGenetic TestingPreconception CarePrenatal CarePrenatal DiagnosisCost-Effectiveness AnalysisAdultFemaleHumansInfant, NewbornMalePregnancyChina

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, the First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.
  • NHC Key Laboratory of Study on Abnormal Gametes and Reproductive Tract, Anhui Medical University, Hefei, Anhui, China.
  • Engineering Research Center of Biopreservation and Artificial Organs, Ministry of Education, Hefei, Anhui, China.

ORCID-Profile: Jing Yuan

Förderung

  • National Key Research and Development Program of China Stem Cell and Translational Research

Zitieren

APA

Yang, Y., Hang, Y., Cheng, W., Cao, Y., Wei, Z., & Yuan, J. (2026). Optimizing expanded carrier screening for China: Multi-center study establishes 202-gene panel with optimal cost-effectiveness in preconception and prenatal care. PLOS One. https://doi.org/10.1371/journal.pone.0338642

Vancouver

Yang Y, Hang Y, Cheng W, Cao Y, Wei Z, Yuan J. Optimizing expanded carrier screening for China: Multi-center study establishes 202-gene panel with optimal cost-effectiveness in preconception and prenatal care. PLOS One. 2026. doi:10.1371/journal.pone.0338642

BibTeX
@article{Yang2026,
  author = {Yang, Yulu and Hang, Yuting and Cheng, WeiSheng and Cao, Yunxia and Wei, Zhaolian and Yuan, Jing},
  title = {Optimizing expanded carrier screening for China: Multi-center study establishes 202-gene panel with optimal cost-effectiveness in preconception and prenatal care},
  journal = {PLOS One},
  year = {2026},
  doi = {10.1371/journal.pone.0338642}
}
Kostenlos starten →